[1]黄应钟,杨立进.序贯抗骨质疏松对老年股骨粗隆间骨折愈合时间及再骨折的影响[J].医学信息,2021,34(18):94-98.[doi:10.3969/j.issn.1006-1959.2021.18.024]
　HUANG Ying-zhong,YANG Li-jin.The Effect of Sequential Anti-osteoporosis on the Healing Time ofIntertrochanteric Fracture and Re-fracture in the Elderly[J].Medical Information,2021,34(18):94-98.[doi:10.3969/j.issn.1006-1959.2021.18.024]
点击复制

序贯抗骨质疏松对老年股骨粗隆间骨折愈合时间及再骨折的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年18期
页码:
94-98
栏目:
论著
出版日期:
2021-09-18

文章信息/Info

Title:
The Effect of Sequential Anti-osteoporosis on the Healing Time ofIntertrochanteric Fracture and Re-fracture in the Elderly
文章编号:
1006-1959（2021）18-0094-05
作者:
黄应钟; 杨立进
广州中医药大学顺德医院骨科，广东 佛山 528333
Author(s):
HUANG Ying-zhong; YANG Li-jin
Department of Orthopedics,Shunde Hospital,Guangzhou University of Chinese Medicine,Foshan 528333,Guangdong,China
关键词:
降钙素; 唑来膦酸; 股骨粗隆间骨折; 骨质疏松; 再骨折
Keywords:
Calcitonin; Zoledronic acid; Intertrochanteric fracture of femur; Osteoporosis;  Re-fracture
分类号:
R687.3
DOI:
10.3969/j.issn.1006-1959.2021.18.024
文献标志码:
A
摘要:
目的 探讨序贯抗骨质疏松治疗对老年骨质疏松性股骨粗隆间骨折愈合时间及再骨折的影响。方法 选取我院2017年11月-2018年9月收治的120例老年股骨粗隆间骨折行PFNA手术患者作为研究对象，按照随机数字法分为对照组、降钙素组及序贯疗法组，各40例。对照组行PFNA治疗，补充钙剂、活性维生素D，降钙素组在对照组的基础上给予鲑鱼降钙素治疗，序贯组在降钙素疗程结束后静滴唑来膦酸序贯治疗。比较三组VAS评分、Harris评分、骨折愈合时间、骨密度、骨代谢指标[血清Ⅰ型前胶原氨基末端前肽（PINP）、Ⅰ型胶原蛋白交联羧基末端肽（β-CTX）]、并发症及其他部位再骨折情况。结果 治疗后1、3及12个月，三组VAS评分、Harris评分较治疗前均改善，且降钙素组及序贯组较对照组的改善效果更好，差异均有统计学意义（P＜0.05）；治疗后12个月，序贯组VAS评分、Harris评分较降钙素组改善，差异有统计学意义（P＜0.05）；降钙素组及序贯组骨折愈合时间短于对照组，差异有统计学意义（P＜0.05）；治疗12个月，降钙素组及序贯组骨密度和骨代谢指标均优于对照组，且序贯组优于降钙素组，差异有统计学意义（P＜0.05）；三组均未出现骨折延迟愈合及不愈合，但降钙素组及序贯组并发症及其他部位再骨折发生率高于对照组，差异有统计学意义（P＜0.05）。结论 降钙素联合唑来膦酸的序贯抗骨质疏松治疗老年骨质疏松性股骨粗隆间骨折疗效可靠，可有效提高患者骨密度，促进骨折愈合，降低再骨折的风险，安全性良好。
Abstract:
Objective To investigate the effect of sequential anti-osteoporosis treatment on the healing time and re-fracture of elderly osteoporotic femoral intertrochanteric fractures.Methods A total of 120 elderly patients with intertrochanteric fractures of the femur who underwent PFNA surgery, who were admitted to our hospital from November 2017 to September 2018, were selected as the research objects. They were divided into control group, calcitonin group and sequential therapy group according to the random number method. 40 cases each.The control group was treated with PFNA, supplemented with calcium and active vitamin D, the calcitonin group was treated with salmon calcitonin on the basis of the control group, and the sequential group was treated with intravenous zoledronic acid after the end of the calcitonin course. Comparing the three groups of VAS score, Harris score, fracture healing time, bone density, bone metabolism indicators [serum type I procollagen amino terminal propeptide (PINP), type I collagen cross-linked carboxy terminal peptide (β-CTX)],complications and re-fractures in other parts.Results 1, 3 and 12 months after treatment, the VAS scores and Harris scores of the three groups were improved compared with those before the treatment, and the calcitonin group and the sequential group had better improvement effects than the control group,the differences were statistically significant (P＜0.05);12 months after treatment, the VAS score and Harris score of the sequential group were better than those of the calcitonin group,the difference was statistically significant (P<0.05);The fracture healing time of the calcitonin group and the sequential group was shorter than that of the control group,the difference was statistically significant (P＜0.05);After 12 months of treatment, the bone mineral density and bone metabolism indexes of the calcitonin group and the sequential group were better than those of the control group, and the sequential group was better than the calcitonin group, the difference was statistically significant (P<0.05);There was no delayed fracture union or nonunion in the three groups, but the incidence of complications and re-fractures in other parts of the calcitonin group and the sequential group was higher than that of the control group,the difference was statistically significant (P<0.05).Conclusion The sequential anti-osteoporotic effect of calcitonin combined with zoledronic acid in the treatment of elderly osteoporotic intertrochanteric fractures is reliable.It can effectively increase the bone density of patients, promote fracture healing, reduce the risk of re-fracture, and has good safety.

参考文献/References:

[1]林华,包丽华.骨质疏松性骨折临床干预的管控[J].中国骨质疏松杂志,2019,25(5):577-580.[2]艾自胜,张长青,刘粤,等.股骨颈骨折内固定术后随访资料的Harris评分分析[J].中国修复重建外科杂志,2009,23(4):435-439.[3]邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南——骨质疏松性骨折诊断及治疗原则[J].黑龙江科学,2018,9(2):85-88.[4]陈志毅,刘林海,顾振华,等.股骨近端防旋髓内钉内固定治疗高龄骨质疏松性股骨粗隆间骨折的效果[J].中国当代医药,2019,26(10):107-109.[5]向云.PFNA微创治疗老年骨质疏松性股骨粗隆间骨折的效果研究[J].中国伤残医学,2019,27(7):35-36.[6]程静,晁爱军.鲑降钙素治疗髋部骨折的系统评价[J].中国骨质疏松杂志,2015,21(3):326-332.[7]Byun J,Jang S,Lee S,et al.The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture:An Update Meta-analysis[J].Journal of Bone Metabolism,2017,24(1):37-49.[8]Nakamura T,Fukunaga M,Nakano T,et al.Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis:two-year results from a randomized placebo-controlled double-blind study(ZOledroNate treatment in Efficacy to osteoporosis;ZONE study)[J].Osteoporosis International,2017,28(1):389-398.[9]Gokosmanoglu F,Varim C,Atmaca A,et al.The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis:A clinical trial study[J].Journal of Research in Medical Sciences,2016,21(1):112-121.[10]刘海龙,王志刚,龚箭.唑来膦酸对骨质疏松症患者骨痛评分及骨代谢指标的影响研究[J].河北医学,2021,27(1):146-150.[11]李贵红.唑来膦酸对原发性骨质疏松症患者骨密度、骨代谢及脆性骨折发生率的影响[J].中国医药指南,2020,18(26):21-23.[12]张莉丽,王定,刘康,等.降钙素对绝经后骨质疏松性髋部骨折患者血清TRACP5b、BALP和BMD的影响[J].中医正骨,2009,21(9):4-7.[13]武红军,杨兴义,马芬.联合应用钙剂、骨化三醇、降钙素治疗骨质疏松性骨折的临床效果[J].中国社区医师,2019,35(3):73.[14]高飞,周武,谢卯,等.PFNA联合规范化抗骨质疏松药物治疗老年骨质疏松性股骨转子间骨折[J].第二军医大学学报,2017,38(4):437-442.[15]蒋元斌,史政康,徐浩,等.老年股骨粗隆间骨折术后早期应用唑来膦酸治疗骨质疏松的临床疗效[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(1):48-52.[16]陈宝,陈国俊,龚遂良,等.降钙素在老年不稳定型股骨转子间骨折应用[J].中华骨科杂志,2014,34(1):24-28.[17]朱振宗,才忠民,尚平,等.观察PFNA、规范化抗骨质疏松药物治疗联合应用于老年骨质疏松性股骨转子间骨折临床作用[J].北方药学,2020,17(3):73-74.[18]高飞,周武,谢卯,等.PFNA联合规范化抗骨质疏松药物治疗老年骨质疏松性股骨转子间骨折[J].第二军医大学学报,2017,38(4):437-442.[19]陈锐雄,王晓锋,张志文,等.唑来膦酸治疗高龄骨质疏松性不稳定转子间骨折临床效果观察[J].创伤外科杂志,2017(1):45-48.[20]樊书新.鲑鱼降钙素联合唑来膦酸预防老年胸腰段骨质疏松性椎体压缩性骨折的临床疗效[J].中国执业药师,2019,16(8):108-111.

相似文献/References:

[1]牟 婷,张朝阳.胰岛素联合唑来膦酸治疗糖尿病骨质疏松症对患者血清指标的影响[J].医学信息,2019,32(22):135.[doi:10.3969/j.issn.1006-1959.2019.22.045]
　MU Ting,ZHANG Chao-yang.Effect of Insulin Combined with Zoledronic Acid on Serum Markers in Patients with Diabetic Osteoporosis[J].Medical Information,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.22.045]
[2]李 博.唑来膦酸联合放疗治疗恶性肿瘤骨转移患者的效果[J].医学信息,2020,33(09):138.[doi:10.3969/j.issn.1006-1959.2020.09.044]
　YU Shou-jie,JIA Qian.The Effect of Zoledronic Acid Combined with Radiotherapy in Patients with Bone Metastases from Malignant TumorsLI Bo[J].Medical Information,2020,33(18):138.[doi:10.3969/j.issn.1006-1959.2020.09.044]
[3]李垄英,王启平,黄 慧.唑来膦酸、化疗联合多维度协同管理治疗非小细胞肺癌骨转移的疗效及对患者疼痛程度和生活质量的影响[J].医学信息,2022,35(21):98.[doi:10.3969/j.issn.1006-1959.2022.21.023]
　LI Long-ying,WANG Qi-ping,HUANG Hui.Efficacy of Zoledronic Acid and Chemotherapy Combined with Multidimensional Collaborative Management in the Treatment of Bone Metastasis of Non-small Cell Lung Cancer and its Effect on Pain Degree and Quality of Life[J].Medical Information,2022,35(18):98.[doi:10.3969/j.issn.1006-1959.2022.21.023]
[4]李泽芹.降钙素联合阿仑膦酸盐治疗原发性骨质疏松症有效性评价[J].医学信息,2021,34(17):154.[doi:10.3969/j.issn.1006-1959.2021.17.041]
　LI Ze-qin.Evaluation of the Effectiveness of Calcitonin Combined with Alendronate Sodium in the Treatment of Primary Osteoporosis[J].Medical Information,2021,34(18):154.[doi:10.3969/j.issn.1006-1959.2021.17.041]
[5]朱道信,罗志环,陈少健,等.唑来膦酸联合骨化三醇对骨质疏松症患者骨密度及骨代谢相关指标的影响[J].医学信息,2021,34(23):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]
　ZHU Dao-xin,LUO Zhi-huan,CHEN Shao-jian,et al.Effect of Zoledronic Acid Combined with Calcitriol on Bone Mineral Density and Bone Metabolism in Patients with Osteoporosis[J].Medical Information,2021,34(18):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]
[6]崔宁宁,穆春梅,王 文,等.唑来膦酸联合经皮穿刺椎体后凸成形术治疗骨质疏松性椎体压缩骨折临床疗效的Meta分析[J].医学信息,2023,36(20):53.[doi:10.3969/j.issn.1006-1959.2023.20.010]
　CUI Ning-ning,MU Chun-mei,WANG Wen,et al.Meta-analysis of Clinical Efficacy of Zoledronic Acid Combined with Percutaneous Kyphoplasty in the Treatment of Osteoporotic Vertebral Compression Fractures[J].Medical Information,2023,36(18):53.[doi:10.3969/j.issn.1006-1959.2023.20.010]
[7]张克斌,杜 杰,彭 英.应用唑来膦酸预防实体瘤骨相关事件的疗效及生存研究[J].医学信息,2024,37(01):109.[doi:10.3969/j.issn.1006-1959.2024.01.018]
　ZHANG Ke-bin,DU Jie,PENG Ying.Study on the Efficacy and Survival of Zoledronic Acid in Preventing Skeletal Related Events in Solid Tumors[J].Medical Information,2024,37(18):109.[doi:10.3969/j.issn.1006-1959.2024.01.018]

更新日期/Last Update: 1900-01-01